Minghan Wang

Resveratrol is Not a Direct Activator of SIRT1 Enzyme Activity

Dirk Beher, John Y. Wu, Suzanne Cumine et al. · Chemical Biology & Drug Design · 2009 · 421 citations

Artificial Sirt1 Substrate, Reductive Stress, Biosynthesis +15

The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome

Minghan Wang · Nutrition & Metabolism · 2005 · 273 citations · Full text

Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex

Ian N. Foltz, Sylvia Hu, Chadwick King et al. · Science Translational Medicine · 2012 · 211 citations

Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance

Clarence Hale, Michelle Chen, Shanaka Stanislaus et al. · Endocrinology · 2011 · 179 citations

Metabolic Disorder, Caloric Restriction, Potential Fgf21 Resistance +25

FGF21 N‐ and C‐termini play different roles in receptor interaction and activation

Junming Yie, Randy Hecht, Jennifer Patel et al. · FEBS Letters · 2008 · 149 citations

Cellular Physiology, Molecular Pharmacology, Signaling Pathway +18